+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Apellis Pharmaceuticals - logo

Apellis Pharmaceutical was founded in 2009 in Crestwood, U.S.A. It is a company with the aim of innovating and creating products to treat autoimmune and inflammatory diseases. Our lead compounds are designed to broadly inhibit complement C3, which is the central protein in the complement system.The complement system plays a key role in a wide range of autoimmune and inflammatory diseases. They believe with the use of C3 inhibition it may correct the immunological dysfunction. The approach they apply to this process is known as complement immunotherapy.

Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • February 2022
  • 131 Pages
  • Global
From
IgA Nephropathy Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

IgA Nephropathy Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 190 Pages
  • Global
From
Artificial Intelligence (AI) in Clinical Trials Market Report 2025 - Product Thumbnail Image

Artificial Intelligence (AI) in Clinical Trials Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • November 2018
  • 164 Pages
  • Global
From
Geographic Atrophy Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Geographic Atrophy Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Drugs for PNH Market - Global Forecast 2025-2030 - Product Thumbnail Image

Drugs for PNH Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Pegcetacoplan Injection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pegcetacoplan Injection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Complement 3 Glomerulopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Complement 3 Glomerulopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Wearable Injectors Market Report 2025 - Product Thumbnail Image

Wearable Injectors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Age-Related Macular Degeneration - Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Age-Related Macular Degeneration - Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2023
  • 115 Pages
  • Global
From
Amyotrophic Lateral Sclerosis- Pipeline Insight, 2025 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 267 Pages
  • Global
From
Complement C3 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C3 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Geographic Atrophy (GA) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Geographic Atrophy (GA) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • June 2022
  • 320 Pages
  • Global
From
Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 242 Pages
  • Global
From
IgA Nephropathy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

IgA Nephropathy Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Asia Pacific Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 125 Pages
  • Asia Pacific
From
Europe Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 126 Pages
  • Europe
From
Loading Indicator